Space radiobiology and the new era of induced radioresistance: should traditional concepts be moved to science history museums?
Energetic solar particle events (SPE) which are among the main sources of ionizing radiation can be life threatening to astronauts who are not adequately protected. To date, physical shielding of spacecrafts and inducing radioresistance by using radioprotectors have been proposed by different investigators. Mortazavi et al. have previously reported that screening of the candidates of long-term space missions by conducting Ground-based in vitro adaptive response studies before any mission identifies the individuals who respond well to low levels of ionizing radiation and reveal high magnitudes of radioadaptive response. On the other hand, Mortazavi et al. have recently showed that radiofrequency-induced adaptive response can be used as a method for decreasing the risk of infection caused by immunosuppression during deep space missions. Furthermore, over the past years the radioresistance induced by a wide variety of radioprotectors has been studied. According to classical radiobiology, chemical radioprotective agents must be administered before irradiation or at the time of irradiation, to increase the mean survival rate of the exposed individuals. A revolution in this paradigm was started in 2010, when investigators reported that a diet supplemented with antioxidants administered starting 24 h after total-body irradiation is more effective than if given soon after the exposure (radiation mitigation). This finding along with the above mentioned interventions open new horizons in inducing biological radioresistance against unpredictable high levels of radiation due to solar particle events. This wide time window indeed enables astronauts to firstly evaluate their radiation doses before making any decision on the type of intervention. As major solar particle events last for hours, astronauts will be able to consult distinguished radiation biologists via satellite telecommunication before choosing any medical intervention.
Medical Physics Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. mmortazavi@sums.ac.ir
S M J
SM
Mortazavi
D018480:Astronauts; D003359:Cosmic Radiation / Q000009:adverse effects; D006801:Humans; D011829:Radiation Dosage; D011837:Radiation-Protective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D011853:Radiobiology; D013026:Space Flight
D011837:Radiation-Protective Agents